Quest Diagnostics DGX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.08B+13.4% | $1.05B+13.6% | $1.03B+15.3% | $1B+12.8% | $948M+5.5% | ||
| $577M+11.6% | $570M+15.6% | $560M+19.9% | $543M+19.9% | $517M+15.4% | ||
| $86M-2.3% | $88M0.0% | $90M+12.5% | $89M+12.7% | $88M+17.3% | ||
| —— | —— | $152M+590% | $57M+183% | $38M+160% | ||
| —— | —— | —— | —— | —— | ||
| $170M— | $129M— | —— | —— | —— | ||
| —— | —— | —— | $9M-88.6% | $68M+65.9% | ||
| —— | —— | —— | —— | —— | ||
| $1.85B+23.8% | $1.89B+41.4% | $1.89B+34.9% | $1.68B+34.5% | $1.49B+12.2% | ||
| $524M+19.6% | $527M+24.0% | $492M+31.6% | $454M+21.7% | $438M+13.8% | ||
| $139M-93.1% | $101M-95.3% | $434M-75.6% | $1.93B+673% | $2.02B+180% | ||
| —— | —— | $16M+433% | -$13M-244% | -$12M-233% | ||
| -$668M+72.7% | -$631M+75.2% | -$942M+56.4% | -$2.37B-274% | -$2.45B-120% | ||
| $357M+6.3% | $353M+6.6% | $347M+6.1% | $342M+5.9% | $336M+5.3% | ||
| $195M-90.5% | $410M-77.8% | $410M-85.0% | $2.25B+55.4% | $2.06B-15.9% | ||
| $413M-54.3% | $1.01B+234% | $1.01B+40.6% | $1B-23.8% | $903M-47.0% | ||
| $115M+27.8% | $79M+8.2% | $82M+28.1% | $87M+64.2% | $90M+52.5% | ||
| $45M-16.7% | $56M+19.1% | $55M+7.8% | $58M+23.4% | $54M0.0% | ||
| $40M— | $45M— | —— | —— | —— | ||
| $16M— | $39M— | -$4M— | —— | —— | ||
| -$979M— | -$1.39B— | —— | —— | —— | ||
| —— | —— | —— | -$2M— | -$6M— | ||
| —— | —— | —— | —— | -$286M-196% | ||
| $3M-40.0% | $3M-40.0% | $3M-40.0% | $4M-20.0% | $5M+66.7% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | $16M+433% | -$13M-244% | -$12M-233% | ||
| $195M-90.5% | $410M-77.8% | $410M-85.0% | $2.25B+55.4% | $2.06B-15.9% | ||
| $16M— | $39M— | -$4M— | —— | —— | ||
| $413M-54.3% | $1.01B+234% | $1.01B+40.6% | $1B-23.8% | $903M-47.0% | ||
| $1.33B+25.6% | $1.36B+49.5% | $1.39B+36.2% | $1.22B+39.9% | $1.06B+11.5% | ||
| $1.33B+25.6% | $1.36B+49.5% | $1.39B+36.2% | $1.22B+39.9% | $1.06B+11.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Quest Diagnostics generate?
- Quest Diagnostics (DGX) generated $1.9B in operating cash flow over the trailing twelve months.
- What is Quest Diagnostics's free cash flow?
- After $524.0M of capital expenditures, Quest Diagnostics's free cash flow was $1.3B over the trailing twelve months, up 25.6% year over year.
- Where does Quest Diagnostics's cash flow data come from?
- Every line is extracted from Quest Diagnostics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
